CBD
William Acevedo, Wendel, Rosen Black & Dean: In 2019 CBD will prove problematic for US-based companies. Likely encouraged by investments by tobacco and alcohol brands in Canadian companies, the departure of Jeff Sessions, and lax enforcement by the FDA of its prohibition of CBD as a food ingredient, companies will misread the signs and make and/or continue to make unsubstantiated claims about the effect(s), if any, of CBD within their products.